ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1408

Color Doppler Ultrasound Is a Reliable Method for Imaging the Lacrimal Glands in Patients with Suspected Sjögren’s Disease

Ting Yang1, Neils Sluijpers1, Jolien van Nimwegen1, Alja Stel1, Adriaan Coumou1, Frans Kroese2, Hendrika Bootsma3, Konstantina Delli1 and Sarah Pringle2, 1UMCG, Groningen, Netherlands, 2University Medical Center Groningen, Groningen, Netherlands, 3Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Groningen, Netherlands

Meeting: ACR Convergence 2024

Keywords: longitudinal studies, Sjögren's syndrome, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Sjögren's Syndrome – Basic & Clinical Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: As a widely available, non-invasive and repeatable technique, ultrasound has already been used for the examination of irregularities of the major salivary glands. However, the studies on lacrimal gland (LG) ultrasound of SjD patients are still limited. To investigate whether ultrasound of the LG is a reliable detection modality, we conducted this study based on Hocevar and OMERACT scoring systems. Our objectives were to assess the interobserver and intraobserver reliability of ultrasound and color Doppler of LGs in patients clinically suspected of SjD.

Methods: 40 consecutive outpatients with suspected SjD underwent ultrasound and color Doppler imaging of the LGs. Four blinded observers scored the images independently in two separate sessions. OMERACT scoring of both greyscale and color Doppler was performed (both total scores range from 0-6) with images and videos. Items from the scoring system of Hocevar et al, were also assessed in both LGs, including echogenicity (compared to the surrounding tissue), parenchymal homogeneity, presence of hypoechogenic areas, hyperechogenic reflections, clearness of posterior glandular border and visibility (total score range 0-26). The interobserver and intraobserver reliability were calculated using intraclass correlation coefficient (ICC) and the ICC values were interpreted as follows: 0.00-0.20: poor;0.20-0.40: fair;0.40-0.60: moderate; 0.60-0.80: good; and 0.80-1.00: excellent.

Results: An example of LG images scored is given in Figure 1. The interobserver reliability of the OMERACT score of the LG were poor to fair, with ICCs of 0.234 and 0.158 in session one and session two, respectively, and the intraobserver reliability fair to moderate, (ICCs 0.270 to 0.536 for 4 observers in the 2 sessions). When the OMERACT scoring system was employed for color Doppler images however, a good interobserver reliability score in both scoring sessions was observed (ICCs 0.633 and 0.690), complemented by a good intraobserver reliability (ICCs 0.614 and 0.799 4 observers in the 2 sessions). In B-mode ultrasound image evaluation, using the Hocevar scoring system, interobserver reliability was fair (ICCs are 0.247 and 0.305), and that of intraobserver reliability fair to moderate (ICCs 0.340 and 0.490). Concerning the individual variables in Hocevar scoring system, the interobserver reliability of all the variables were poor to fair with ICCs less than or equal to 0.400.

Conclusion: Our single center study shows that Color Doppler ultrasound based on the OMERACT scoring system is more reliable than B-mode ultrasound for evaluation of the lacrimal gland in patients with clinically suspected SjD. Conversely, classical B-mode ultrasound used for the major salivary glands of SjD patients  is unreliable for the assessment of LGs, regardless of whether the Hocevar or OMERACT scoring system is employed.

Supporting image 1

Figure1: Examples of low-scoring and high scoring lacrimal gland ultrasound using Hocevar and Omeract scoring system.
A: Ultrasound image of the left LG with an average Hocevar score of 0.5 and average greyscale OMERACT score of 0.25.
B: Ultrasound image of the left LG with an average Hocevar score of 8.25 and average greyscale OMERACT score of 2.75.
C: Color Doppler image of the left LG with an average color Doppler OMERACT score of 0.25.
D: Color Doppler image of the left LG with an average color Doppler OMERACT score of 2.25.


Disclosures: T. Yang: None; N. Sluijpers: None; J. van Nimwegen: None; A. Stel: None; A. Coumou: None; F. Kroese: None; H. Bootsma: Argenx, 2, AstraZeneca, 2, 12, Funding, Bristol Myers Squibb, 2, 12, Funding, Galapagos, 2, Novartis, 2, 12, Funding, Roche, 2, 12, Funding, Sanofi, 2, UCB, 2; K. Delli: None; S. Pringle: None.

To cite this abstract in AMA style:

Yang T, Sluijpers N, van Nimwegen J, Stel A, Coumou A, Kroese F, Bootsma H, Delli K, Pringle S. Color Doppler Ultrasound Is a Reliable Method for Imaging the Lacrimal Glands in Patients with Suspected Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/color-doppler-ultrasound-is-a-reliable-method-for-imaging-the-lacrimal-glands-in-patients-with-suspected-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/color-doppler-ultrasound-is-a-reliable-method-for-imaging-the-lacrimal-glands-in-patients-with-suspected-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology